Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone

Description

Major depressive disorder (MDD) is highly prevalent and nearly 70% of individuals with MDD do not respond to standard antidepressant therapies despite adequate dosing. An effective and well-tolerated antidepressant augmentation therapy would have important clinical and public health implications. Neuroactive steroid hormones are known to directly activate neurotransmitter receptors in the brain, and thus are potential candidates for augmentation therapies to enhance the effect of traditional antidepressants. The investigators hypothesize that administration of an allopregnanolone analog in women with treatment-resistant depression will improve depressive symptoms.

Study Start Date

November, 01 2016

Estimated Completion Date

January 2019

Interventions

  • Drug: CCD-1042

Study ID

Massachusetts General Hospital -- 2016P001182

Status

Recruiting

Trial ID

NCT02900092

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

10

Sponsor

Massachusetts General Hospital

Inclusion Criteria

    1. Female, age 50-75 2. Postmenopausal 3. Major Depressive Disorder 4. Currently treated with SSRI or SNRI at adequate dose

Exclusion Criteria

    1. Serious suicide or homicide risk 2. Unstable medical illness 3. Substance use disorder 4. Psychosis 5. Use of hormones (estrogens, androgens or related hormones) 6. History of hormone responsive cancer 7. Receiving strong CYP3A4 inducers or inhibitors or who intend to consume grapefruit products regularly during the study 8. Alanine aminotransferase (ALT) or creatinine > 3x upper limit of normal

Gender

Female

Ages

50 Years to 75 Years

Accepts Healthy Volunteers

No

Study Locations and Contact Information (6)

Study Location Distance Name Phone Email
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Laura Dichtel MD 617-726-3870 LDichtel@partners.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.